Joseph Brown
University of Connecticut
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joseph Brown.
Annals of the New York Academy of Sciences | 1994
Joseph Brown; Thomas F. Babor; Mark D. Litt; Henry R. Kranzler
Multidimensional typologies of alcoholics are reviewed, including Cloningers neurobiological learning model, Morey and Skinners hybrid model, and Zuckers developmental model. The more recent Type A/Type B typology proposed by Babor and colleagues is reviewed in more depth, as is a previous replication and extension by Litt and colleagues. Both the original study and the replication indicate this typology is a useful tool in classifying alcoholic inpatients into two groups and in matching alcoholics to the most suitable treatment. The present study replicates the typology using outpatient samples of male alcoholics. The resulting two clusters are very similar to those identified by the two earlier studies. As expected, the relative proportion of Type A alcoholics is higher in the outpatient samples than in the previously studied inpatient samples. Preliminary analysis of the typologys clinical efficiency suggests that the variables used to classify subjects might be appreciably reduced, thus effecting a considerable time savings in assessment. A discriminant function analysis indicates that using only 5 of the original 16 clustering variables results in a correct classification rate of almost 95%. Future research directions are addressed.
Journal of Substance Abuse Treatment | 1993
Henry R. Kranzler; Frances K. Del Boca; Patricia Korner; Joseph Brown
Open-label and placebo-controlled trials of fluvoxamine, a selective, serotonergic antidepressant, were conducted as an adjunct to relapse prevention psychotherapy in alcoholics. In the open trial, 16 inpatient alcoholics began a 12-week treatment program, with 10 patients dropping out during the first 4 weeks of treatment. In the controlled trial, 8 of 10 patients on fluvoxamine dropped out during the first 4 weeks of treatment, compared with only 1 of 9 patients on placebo. Baseline patient characteristics did not appear to explain the differential attrition in the controlled trial, although the placebo-treated patients were more alcohol dependent. In both trials, patients on fluvoxamine complained of a variety of adverse effects, which they often identified as the basis for early termination of treatment. These adverse effects appear to limit the usefulness of the medication for the treatment of alcoholism.
Psychosomatics | 1992
Joseph Brown; Mahlon S. Hale
Several authors recently have proclaimed the need for empirically based research articles in consultation-liaison psychiatry. The authors report that although the proportion of empirically based studies published in Psychosomatics increased 148% from 1979 to 1989, the power of statistical analyses and the deleterious effect of multiple tests were often neglected. A power analysis of empirical studies published in the 1989 volume year of Psychosomatics is reported, showing statistical power to be low for all but the most robust of effect sizes.
American Journal of Psychiatry | 1995
Henry R. Kranzler; Joseph A. Burleson; Patricia Korner; Del Boca Fk; Michael J. Bohn; Joseph Brown; Liebowitz N
Archives of General Psychiatry | 1994
Henry R. Kranzler; Joseph A. Burleson; Frances K. Del Boca; Thomas F. Babor; Patricia Korner; Joseph Brown; Michael J. Bohn
Alcoholism: Clinical and Experimental Research | 1996
Henry R. Kranzler; Joseph A. Burleson; Joseph Brown; Thomas F. Babor
Addiction | 1992
Joseph Brown; Henry R. Kranzler; Frances K. Del Boca
Alcoholism: Clinical and Experimental Research | 1996
Frances K. Del Boca; Henry R. Kranzler; Joseph Brown; Patricia Korner
Journal of Bacteriology | 1963
Patricia MacLeod; Joseph Brown
Alcoholism: Clinical and Experimental Research | 1982
Joseph P. Lyons; John W. Welte; Joseph Brown; Lloyd Sokolow; Gerard Hynes